CD8A and nonpapillary renal cell carcinoma: Similarly, Giraldo et al. evaluated the immune microenvironment of metastatic ccRCC tumors and demonstrated patients with high CD8+ infiltration had about a twofold increase in risk of mortality compared to tumors with low CD8+ infiltration [82].